Now Available From
DRG International

Introducing the DRG COVID-19 and Influenza A+B Antigen Rapid Tests manufactured and distributed by DRG International for Non-US Customers Only.

DRG-Intl_SARS-CoV-2_RBD_ELISAs_Covid-19-RAP_2021-v7

COVID-19 Antigen Rapid Test Kits

SKU: RAP-6171
20 Tests

DRG-Intl_SARS-CoV-2_RBD_ELISAs_Covid-19-RAP_2020-11-12-v6

COVID-19 Ag Influenza A+B Ag Rapid Test

SKU: RAP-6172
20 Tests

DRG-Intl_SARS-CoV-2_RBD_ELISAs_Covid-19-RAP_2021-v7

COVID-19 Antigen Rapid Test Kits

SKU: RAP-6171
20 Tests

DRG-Intl_SARS-CoV-2_RBD_ELISAs_Covid-19-RAP_2020-11-12-v6

COVID-19 Ag Influenza A+B Ag Rapid Test

SKU: RAP-6172
20 Tests

Benefits at a Glance :

  • Aids in early diagnosis of COVID-19
  • Differentiates COVID-19, Influenza A, and Influenza B
  • Fast and easy testing anytime-anywhere, no equipment needed
  • Easy sampling with nasopharyngeal swab (included)
  • Fast procedure; results within 15 minutes
  • Visual interpretation of results
  • Highly sensitive and specific

DRG COVID-19 Antigen Rapid Tests

Z

Benefits at a Glance

  • Aids in early diagnosis of COVID-19
  • Differentiates COVID-19, Influenza A, and Influenza B
  • Fast and easy testing anytime-anywhere, no equipment needed
  • Easy sampling with nasopharyngeal swab (included)
  • Fast procedure; results within 15 minutes
  • Visual interpretation of results
  • Highly sensitive and specific

COVID-19 Antigen Rapid Test (RAP-6171)
– 20 Tests

Direct antigen detection from the site of infection helps in early diagnosis of COVID-19 as it plays an important role for virus detection in the early stage of disease. SARS-COV-2 antigen is generally detectable in upper respiratory specimen during the acute phase of infection.

COVID-19 Ag / Influenza A+B Ag Rapid Test (RAP-6172)
– 20 Tests

Most common symptoms of COVID-19 are fever, dry cough and tiredness. Some of the symptoms of COVID-19 and Influenza are similar; it may be hard to tell the difference between them based on symptoms alone. Testing can help screen and confirm a diagnosis.

+ Positive results indicate the presence of viral antigens, but clinical correlation with patient history and other diagnostic information is necessary to determine infection status.
Negative results should be treated as presumptive and confirmed with other laboratory tests, if necessary for patient management.

Fast & Easy Screening of COVID-19

DRG-Intl_SARS-CoV-2_RBD_ELISAs_Covid-19-RAP_2021-v7

COVID-19 Antigen Rapid Test
(RAP-6171)

  • Simple operation anytime-anywhere, no equipment needed
  • Easy sampling with nasopharyngeal swab (included)
  • Easy and fast procedure: results within 15 minutes assay time
  • Visually interpretation of results
  • Sensitivity 96.4%*
  • Specificity 99.2%*
  • EU: CE/IVD

 

Fast & Easy Screening of COVID-19

DRG-Intl_SARS-CoV-2_RBD_ELISAs_Covid-19-RAP_2021-v7

COVID-19 Antigen Rapid Test (RAP-6171)

  • Simple operation anytime-anywhere, no equipment needed
  • Easy sampling with nasopharyngeal swab (included)
  • Easy and fast procedure: results within 15 minutes assay time
  • Visually interpretation of results
  • Sensitivity 96.4%*
  • Specificity 99.2%*
  • EU: CE/IVD

COVID-19 Antigen Rapid Test

(RAP-6171)

Training Session DRG Intl_SARS-CoV-2_RBD_ELISAs_Covid-19 RAP_202
Training Session DRG Intl_SARS-CoV-2_RBD_ELISAs_Covid-19 RAP_202

Results within 15 minutes

Screening of COVID-19, Influenza A&B in One Step

DRG-Intl_SARS-CoV-2_RBD_ELISAs_Covid-19-RAP_2020-11-12-v6

COVID-19 Ag / Influenza A+B Ag Rapid Test (RAP-6172)

  • Simple operation anytime-anywhere, no equipment needed
  • Easy sampling with nasopharyngeal swab (included)
  • Easy and fast procedure: results within 15 minutes assay time
  • Visually interpretation of results
  • Sensitivity COVID-19 Ag 96.4%*
  • Specificity COVID-19 Ag 99.2%*
  • Sensitivity Influenza A/B Ag 95.0/92.9%
  • Specificity Influenza A/B Ag 99.1/99.1%
  • EU: CE/IVD

Screening of COVID-19, Influenza A&B in One Step

DRG-Intl_SARS-CoV-2_RBD_ELISAs_Covid-19-RAP_2020-11-12-v6

COVID-19 Ag / Influenza A+B Ag Rapid Test (RAP-6172)

  • Simple operation anytime-anywhere, no equipment needed
  • Easy sampling with nasopharyngeal swab (included)
  • Easy and fast procedure: results within 15 minutes assay time
  • Visually interpretation of results
  • Sensitivity COVID-19 Ag 96.4%*
  • Specificity COVID-19 Ag 99.2%*
  • Sensitivity Influenza A/B Ag 95.0/92.9%
  • Specificity Influenza A/B Ag 99.1/99.1%
  • EU: CE/IVD

COVID-19 Ag / Influenza A+B Ag Rapid Test

(RAP-6172)

Training Session DRG Intl_SARS-CoV-2_RBD_ELISAs_Covid-19 RAP_2020
Training Session DRG Intl_SARS-CoV-2_RBD_ELISAs_Covid-19 RAP_202

Results within 15 minutes

DRG 50 Years IconDRG International Inc: This ELISA is intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection. It can support the diagnosis of COVID-19 disease and supplement direct pathogen detection via RT-PCR or pulmonary CT-Scans. In addition, serology can help to gather epidemiological information on the disease prevalence.

How do I get the DRG COVID-19 Antigen Rapid Tests to my facility?
Click the ‘Shop Now‘ button to order directly from our eStore or click here to contact us for more information, and connect with a regional DRG International Sales Representative

– “Due to Regulatory Restrictions, sales of these products may not be available in your territory. The SARS kits are CE/IVD in the EU”
Disclaimer: The information contained in this communication from the sender is confidential. It is intended solely for use by the recipient and others authorized to receive it. If you are not the intended recipient, you are hereby notified that any disclosure, copying, use, or distribution of the information included in this email is prohibited and may be unlawful.

Search Our Products